跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ginsenoside Rh3
首页
药物
Ginsenoside Rh3
Ginsenoside Rh3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Secondary ginsenoside composition and application thereof in prevention and treatment of pulmonary fibrosis and acute lung injury
CN 119367376 A
申请人: UNIV MACAU SCI & TECH
优先权: 2024
CN
2 件公开
Extract of processed Panax genus plant, the preparation method thereof, and compositions containing the same
US 2003190378 A1
申请人: GINSENG SCIENCE INC
优先权: 2002
US
Novel use of the extract of processed Panax genus plant and saponin compound isolated therefrom
US 2003190377 A1
申请人: GINSENG SCIENCE INC
优先权: 2002
US
Product of ginsenoside for curing AIDS
CN 1425380 A
申请人: YANG SHULING
优先权: 2002
CN
Method for preparing panaxoside monomer Re,Rh1,Rh2,Rg2,Rg3 by using ginseng stem and leaves
CN 101205247 B
申请人: FUSONG COUNTY DAZIRAN BIOLOG ENGINEERING CO LTD
优先权: 2007
CN
Rare monomer ginsenoside composition and preparation method
CN 111388491 A
申请人: HE YINGYI
优先权: 2020
CN
Substance for improving lethality of immune cells as well as preparation and application of substance
CN 112618718 A
申请人: HANDAN PHARMACEUTICAL CO LTD
优先权: 2020
CN
Preparation method of ginseng root fermentation product filtrate capable of enhancing oxidation resistance
CN 114642619 A
申请人: CHINESE HERBAL AND HAAN AROMATIC BIOTECHNOLOGY GUANGZHOU LTD COMPANY
优先权: 2022
CN
Application of notoginsenoside component in preparation of anticoagulant medicine
CN 120204244 A
申请人: UNIV BEIJING
优先权: 2023
CN
药物
反馈